Symbols

YB

Yuanbao·NASDAQ

--(--)

YB fundamentals

YB Q4 2025 Earnings

Yuanbao (YB) released its earnings on Mar 18, 2026: revenue was 168.03M (YoY --), beat estimates; EPS was 0.1658 (YoY --), missed estimates.

Revenue / YoY

168.03M

EPS / YoY

0.1658

Report date

Mar 18, 2026

YB Earnings Call Summary for Q4,2025

Revenue Surge: Q4 2025 revenue up 32.2% YoY to RMB 1.18 billion, driven by AI-integrated insurance distribution and system services.
Profitability Strength: 14 consecutive quarters of net income growth, with full-year net margin improving to 29.9%.
AI-Driven Efficiency: AI agents now handle 30%+ of customer interactions, reducing costs and improving service consistency.
Policy Catalysts: National drug catalog expansion and long-term care insurance mandates create RMB 10+ billion market opportunity for inclusive insurance products.
Growth Momentum: 2026 guidance for stable marketing costs as % of revenue, with focus on AI-driven customer acquisition and retention.

Earnings

EPS

Revenue

Revenue & Expenses

YB has released its 2025 Q4 earnings report, with revenue of 168.06M, reflecting a YoY change of 38.03%, and net profit of 48.25M, showing a YoY change of 20.48%. The Sankey diagram below clearly presents YB's revenue sources and cost distribution.

Key Indicators

Yuanbao (YB) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Yuanbao (YB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Yuanbao (YB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Yuanbao (YB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown